RSS

licensing agreement

Lonza and BioWa have entered into a licensing agreement with Tillotts Pharma for the POTELLIGENT CHOK1SV Cell Line Technology to be used in research and development of the proprietary antibody TP10. more

Technology

Contract development and manufacturing organisation (CDMO), Recipharm, has signed a licensing agreement with Canadian drug development company, Altus Formulation, to offer new drug delivery technologies for value added medicines. more

Technology

An exclusive licensing agreement has been announced by DNA Script and Dynamic Combinatorial Chemistry (DCC), which will see the companies expand the use of a novel DNA building block to synthesize high purity synthetic DNA and other nucleic acids. more

Technology

Oxford Genetics and Twist Bioscience have signed a new licensing agreement for the SnapFast technology platform. more

Technology

Biotechnology company, GamaMabs Pharma, and the global biologics R&D arm of AstraZeneca, MedImmune, have entered into a licensing agreement for the development of an antibody drug conjugate (ADC) to target cancer. more

News

The Lead Discovery Center (LDC), Max Planck Innovation and SOTIO have signed a collaboration and licence agreement providing SOTIO with exclusive rights to an oncology programme addressing a novel target in tumour metabolism. more

News

RedHill Biopharma has signed an exclusive licensing agreement for the commercialisation of Entera Health’s gastrointestinal speciality products, Donnatal and EnteraGam. more

News

The Berlin Institute of Health (BIH) has introduced the digital laboratory data management platform from labfolder through a licence agreement. more

Technology

According to research and consulting firm GlobalData, pharmaceutical companies are adopting a broad range of strategies to effectively compete in the tauopathies space. more

News

Distribution, licence and supply agreement announced with Medical Developments International more

afrezza.jpg

Copyright: MannKind Corporation

The new rapid-acting inhaled insulin therapy is for treating adults with type 1 and type 2 diabetes. more